2015 - RAS Dialogue
- Mutations in Human Cancers Through the Lens of KRAS
Exome sequences from The Cancer Genome Atlas were analyzed for the types of missense mutations in KRAS that were associated with missense mutations in other commonly mutated genes.
- Nanotechnology for Treating Cancer: Pitfalls and Bridges on the Path to Nanomedicines
Despite their promise, only a few nano-formulated drugs are used in humans. The NCI Nanotechnology Characterization Lab helps companies and academic investigators maximize their chance of successful clinical use.